LIFR and breast carcinoma: In addition, it has been shown that rapamycin, an inhibitor of the mTOR pathway, suppresses the promoting effect of LIF on tumorigenesis and metastasis in breast cancer cells [64] and that combined immunization against LIF and LIFR inhibits tumor formation from mammary CSCs in BALB/c mice [77].